Loading...

Biovica participates at ASCO, June 3-7, Chicago

Biovica will attend the ASCO Annual Meeting, an event that brings together 30 000 oncology professionals from around the world. Biovica aims to expand the collaboration and research network and to share the latest insights from on going clinical trials. “At ASCO we look forward to meet our academic partners and to expand [...]

May 31st, 2016 08:30|News|

Biovica acquires cSens – creating opportunities for solving cancer diagnostic challenges

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. The cSens technology complements Biovica’s current TK assay DiviTum ™, which is currently included in clinical studies with leading cancer institutes throughout the world. [...]

May 17th, 2016 08:30|Press Release|

Maria Holmlund elected new member of Biovica board of directors

Maria Holmlund was elected as a new member of the Biovica board of directors at an extra shareholders meeting held on March 30, 2016. Maria has 30 years of experience in the life science and diagnostic industry and she has previously held senior management positions as CEO, business area manager and marketing manager at [...]

May 4th, 2016 14:00|Press Release|

Poster accepted for presentation at the 2016 aacr annual meeting in New Orleans

The American Association for Cancer Research (AACR) annual meeting is one of the largest gatherings of cancer researchers and oncologists in the world. The meeting is held 16-20 April in New Orleans. Biovica is attending the meeting to present a poster with new DiviTum™ results to demonstrate its use as a marker of efficacy for cell [...]

April 1st, 2016 09:00|News|

Biovica participates at the bio-europe conference, 4-6 april in Stockholm

Biovica will attend one of the largest partnering conferences serving the global biotechnology and pharmaceutical industry. The conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. This years spring meeting is arranged in Stockholm at Kistamässan. “With DiviTum™ we provide researchers and pharmaceutical companies with a tool for [...]

March 18th, 2016 09:00|News|

Biovica expands – recruits senior director us business development

Biovica has strengthened the company’s presence in the  United States by adding Edward M. (Ted) Suh, Ph.D. as Senior Director, US Business Development. Ted received a B.A. degree in chemistry from Yale University, and a Ph.D. degree from Harvard University,  also in chemistry.  Prior to joining Biovica, Ted worked as a medicinal chemist at Glaxo. [...]

February 8th, 2016 09:00|Press Release|

Professor Thomas Helleday at Karolinska Institutet and Biovica in research collaboration to evaluate new promising cancer treatments

The laboratory headed by Thomas Helleday at Karolinska Institutet, (Stockholm) and Biovica (Uppsala) have entered a research collaboration to improve evaluation and development of new, promising cancer therapies. The aim of the collaboration project is to assess whether information gathered with Biovicas DiviTum™ assay has the potential to provide early evidence of efficacy regarding the [...]

January 29th, 2016 11:00|Press Release|

Biovica and the international breast cancer study group & breast international group in collaboration to improve outcome for women with breast cancer

Biovica’s DiviTum™ technology has been selected by the International Breast Cancer Study Group (IBCSG, Bern) and the Breast International Group (BIG, Brussels) to be part of a state of the art trial, studying the effects of palbociclib, a promising new cancer drug. The study, named PYTHIA, will follow women with advanced breast cancer being treated [...]

December 1st, 2015 08:45|Press Release|

Biovica and Simplicitybio, a unique collaboration to offer improved drug development

The biotech company Biovica, inventors of DiviTum™ and SimplicityBio creators of the Biomarker Optimization Software System (BOSS), have agreed to collaborate to discover and improve multi-biomarker panels for faster and better evaluation of cancers and new oncology drugs. Together the companies offer a unique solution to correlate efficacy of novel drugs with patient outcome and [...]

November 20th, 2015 08:00|Press Release|

Meet Biovica at the annual BIO-Europe conference in Munich

Biovica will attend the BIO-Europe conference on November 2-4. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. “Biovica provides pharmaceutical companies and academia with a technology to predict and evaluate efficacy of novel [...]

October 27th, 2015 09:00|News|